Comments on India’s draft biotech patent guidelines posted

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Comments on India’s draft biotech patent guidelines posted

The India Patent Office has released public feedback to its draft guidelines for the examination of biotechnology patents

The guidelines were released on December 11 2013 with a public comment period until January 11. The Patent Office received comments from Indian biotechnology firms, patent law firms, and groups such as the Organisation of Pharmaceuticals Producers of India (OPPO), the Biotechnology Industry Organization (BIO) and even the Japan Intellectual Property Association.

The Spicy IP blog described the publication as a “welcome development”.

The introduction to the draft guidelines state that they are intended to address serious concerns concerning “novelty, obviousness, industrial applicability, extent of disclosure and clarity in claims” which often arise in biotechnology patents. The guidelines also note that there are issues unique to biotechnology, “such as those relating to moral and ethical concerns, environmental safety, issues relating to patenting of ESTs (expressed sequence tags) of partial gene sequences, cloning of farm animals, stem cells, [and] gene diagnostics”.

Representatives of rights holders have expressed concern that the guidelines take too strict a view on patentability. OPPI, the industry group for large international pharmaceutical companies, said in its submission that the guidelines used an overly broad definition of obviousness. It also said that some of the provisions lacked clarity, that some limitations such as the prohibition of patenting methods of treatment appear to be broader in the guidelines’ examples than in the guideline text.

Similarly, Anand & Anand, who represents a number of large international pharmaceutical companies, stressed in its comments that the draft outlines do not have the force of law and argue that some of the illustrations are inconsistent with Patent Office practice.



more from across site and SHARED ros bottom lb

More from across our site

Attorneys explain why there are early signs that the US Supreme Court could rule in favour of ISP Cox in a copyright dispute
A swathe of UPC-related hires suggests firms are taking the forum seriously, as questions over the transitional stage begin
A win for Nintendo in China and King & Spalding hiring a prominent patent litigator were also among the top talking points
Rebecca Newman at Addleshaw Goddard, who live-reported on the seminal dispute, unpicks the trials and tribulations of the case and considers its impact
Attorneys predict how Lululemon’s trade dress and design patent suit against Costco could play out
Lawyers at Linklaters analyse some of the key UPC trends so far, and look ahead to life beyond the transition period
David Rodrigues, who previously worked at an IP boutique, said he may become more involved in transactional work at his new firm
Indian smartphone maker Lava must pay $2.3 million as a security deposit for past sales, as its dispute with Dolby over audio coding SEPs plays out
Powell Gilbert’s opening in Düsseldorf, complete with a new partner hire, continues this summer’s trend of UPC-related lateral movement
IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications
Gift this article